Sorafenib for the treatment of advanced hepatocellular cancer - a UK audit.
Authors
King, JPalmer, D
Johnson, P
Ross, P
Hubner, Richard A
Sumpter, K
Darby, S
Braconi, C
Iwuji, C
Swinson, D
Collins, P
Patel, K
Nobes, J
Muazzam, I
Blesing, C
Kirkwood, A
Nash, S
Meyer, T
Affiliation
Department of Oncology, Royal Free London NHS Foundation Trust, London, UKIssue Date
2016-12-10
Metadata
Show full item recordAbstract
Sorafenib is the current standard treatment for advanced hepatocellular carcinoma. We carried out a national audit of UK patients treated with sorafenib as standard-of-care and those treated with systemic therapy in first-line trials.Citation
Sorafenib for the treatment of advanced hepatocellular cancer - a UK audit. 2016, Clin OncolJournal
Clinical OncologyDOI
10.1016/j.clon.2016.11.012PubMed ID
27964898Type
ArticleLanguage
enISSN
1433-2981ae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2016.11.012
Scopus Count
Collections
Related articles
- The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib.
- Authors: Wörns MA, Koch S, Niederle IM, Marquardt JU, Nguyen-Tat M, Gamstätter T, Schuchmann M, Schulze-Bergkamen H, Galle PR, Weinmann A
- Issue date: 2013 May
- Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma.
- Authors: Ogasawara S, Chiba T, Ooka Y, Suzuki E, Kanogawa N, Saito T, Motoyama T, Tawada A, Kanai F, Yokosuka O
- Issue date: 2015 Dec
- A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma.
- Authors: Edeline J, Blanc JF, Johnson P, Campillo-Gimenez B, Ross P, Ma YT, King J, Hubner RA, Sumpter K, Darby S, Evans J, Iwuji C, Swinson D, Collins P, Patel K, Muazzam I, Palmer DH, Meyer T
- Issue date: 2016 Dec
- Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib use.
- Authors: Kuo YH, Wang JH, Hung CH, Rau KM, Wu IP, Chen CH, Kee KM, Hu TH, Lu SN
- Issue date: 2017 Dec
- Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib.
- Authors: Inghilesi AL, Gallori D, Antonuzzo L, Forte P, Tomcikova D, Arena U, Colagrande S, Pradella S, Fani B, Gianni E, Boni L, Laffi G, Di Costanzo F, Marra F
- Issue date: 2014 Jan 21